JPMORGAN CHASE & CO - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 66 filers reported holding ONCOCYTE CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$714
-28.6%
3,1040.0%0.00%
Q1 2023$1,000
+99900.0%
3,1040.0%0.00%
Q4 2022$1
-100.0%
3,104
-60.2%
0.00%
Q3 2022$6,0000.0%7,808
+22.7%
0.00%
Q2 2022$6,000
-89.8%
6,362
-84.1%
0.00%
Q1 2022$59,000
-14.5%
39,914
+25.0%
0.00%
Q4 2021$69,000
-18.8%
31,926
+34.2%
0.00%
Q3 2021$85,000
-77.0%
23,795
-63.1%
0.00%
Q2 2021$370,000
-43.5%
64,526
-48.9%
0.00%
Q1 2021$655,000
+169.5%
126,244
+24.5%
0.00%
Q4 2020$243,000
+252.2%
101,384
+110.0%
0.00%
Q3 2020$69,000
-2.8%
48,279
+31.0%
0.00%
Q2 2020$71,000
-22.0%
36,865
-0.1%
0.00%
Q1 2020$91,000
+44.4%
36,905
+31.9%
0.00%
Q4 2019$63,000
+215.0%
27,972
+192.8%
0.00%
Q3 2019$20,000
+33.3%
9,553
+61.8%
0.00%
Q2 2019$15,000
-91.7%
5,904
-87.1%
0.00%
Q1 2019$181,00045,773
+15469.0%
0.00%
Q4 2018$0
-100.0%
294
-2.3%
0.00%
Q3 2018$1,0000.0%3010.0%0.00%
Q2 2018$1,000
-50.0%
301
-60.6%
0.00%
Q1 2018$2,000
-60.0%
764
-27.2%
0.00%
Q4 2017$5,0001,050
+2042.9%
0.00%
Q1 2017$0490.0%0.00%
Q4 2016$0490.00%
Other shareholders
ONCOCYTE CORP shareholders Q3 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 14,716,204$20,456,0001.61%
PURA VIDA INVESTMENTS, LLC 6,022,534$8,371,0000.43%
P.A.W. CAPITAL CORP 199,700$278,0000.30%
Penbrook Management LLC 229,425$319,0000.28%
PERKINS CAPITAL MANAGEMENT INC 39,725$55,0000.05%
GSA CAPITAL PARTNERS LLP 201,047$279,0000.05%
Private Wealth Partners, LLC 150,000$209,0000.02%
Phoenix Holdings Ltd. 317,138$426,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 255,300$355,0000.01%
ETF MANAGERS GROUP, LLC 157,933$226,0000.01%
View complete list of ONCOCYTE CORP shareholders